| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $128.3M | -1.7% |
| Cost of Revenue | $79.3M | +10.6% |
| Gross Profit | $49.0M | -16.7% |
| R&D Expense | $193.0M | +70.9% |
| SG&A Expense | $160.9M | +29.6% |
| Operating Income | -$307.2M | -46.0% |
| Interest Expense | $14.7M | +17.2% |
| Pre-tax Income | -$314.2M | -14.3% |
| Income Tax | -$93.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $325.1M | -29.4% |
| Short-term Investments | $447.2M | -23.4% |
| Accounts Receivable | $18.8M | -22.5% |
| Inventory | $50.4M | +104.8% |
| Current Assets | $852.1M | -22.6% |
| Total Assets | $1.77B | -12.0% |
| Current Liabilities | $263.3M | +267.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$263.2M | -136.7% |
| Capital Expenditures | $16.8M | +182.4% |
| Investing Cash Flow | $116.1M | +117.1% |
| Financing Cash Flow | $9.6M | -99.2% |
| Free Cash Flow | -$280.0M | -139.1% |
| +0.0% |
| Net Income | -$314.2M | -73.4% |
| EPS (Basic) | -$1.40 | -57.3% |
| EPS (Diluted) | -$1.40 | -57.3% |
| Long-term Debt |
| $896.7M |
| +0.1% |
| Total Liabilities | $1.20B | -1.0% |
| Stockholders' Equity | $562.9M | -28.8% |